Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-17 Sale | 2020-12-18 4:29 pm | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 88,764 | $53.55 | $4,753,680 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-19 Option Award | 2023-07-21 5:10 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-03 Disposition | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 172,590 | $0 | 0 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:44 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 5,000 | $0 | 0 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:07 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 5:38 pm | N/A 2032-06-20 | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-13 Option Award | 2021-07-01 7:00 pm | N/A 2031-01-12 | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 93,492 | $0 | 277,289 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 7:00 pm | N/A N/A | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 27,889 | $0 | 277,289 (Direct) | View |
| 2021-03-11 Option Award | 2021-07-01 7:00 pm | N/A N/A | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 19,763 | $5.06 | 277,289 (Direct) | View |
Ownership | 2021-06-24 9:14 pm | N/A N/A | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 0 | $0 | 257,526 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 4:34 pm | N/A 2031-06-18 | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $15.78 | 5,000 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 31,764 | $18 | 5,000 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $25.98 | 5,000 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A 2026-05-04 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 88,764 | $0 | 5,000 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:29 pm | N/A N/A | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $14.35 | 5,000 (Direct) | View |
Ownership | 2020-11-18 8:06 pm | N/A N/A | Jiya Acquisition Corp. | JYAC | KARSEN PERRY A Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-06-26 Option Award(A) | 2020-07-02 7:35 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-29 7:34 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director | 13,550 | $0 | 13,550 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-19 4:46 pm | N/A 2030-06-17 | Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director | 19,000 | $0 | 19,000 (Direct) | View |